Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families

Clinical Chemistry

Volumn 48, Issue 11, 2002, Pages 1891-1900

  Kauppinen, Raili ^a   Von und zu Fraunberg, Mikael ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PORPHOBILINOGEN; PORPHOBILINOGEN DEAMINASE; PORPHYRIN;

ABDOMINAL DISEASE; ACUTE INTERMITTENT PORPHYRIA; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; FAMILY HISTORY; FAMILY STUDY; FEMALE; GENE MUTATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; REMISSION;

EID: 0036840651     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.11.1891     Document Type: Article

References (34)

1. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet A, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Diseases, 7th Ed. New York: McGraw-Hill, 1995:2116-27.
2. Raich N, Romeo PH, Dubart A, Beaupain D, Cohen-Solal M, Goossens M. Molecular cloning and complete primary sequence of human erythrocyte PBG deaminase. Nucleic Acids Res 1986;14:5955-68.
3. Grandchamp B, de Verneuil H, Beaumont C, Chretien S, Walter O, Nordmann Y. Tissue-specific expression of porphobilinogen deaminase: Two isoenzymes from a single gene. Eur J Biochem 1987;162:105-10.
4. Chretien S, Dubart A, Beaupain D, Raich N, Grandchamp B, Rosa J, et al. Alternative transcription and splicing of the human porphobilinogen deaminase result either in tissue-specific or in house-keeping expression. Proc Natl Acad Sci U S A 1988;85:6-9.
5. Yoo HW, Warner CA, Chen CH, Desnick RJ. Hydroxymethylbilane synthase: Complete genomic sequence and amplifiable polymorphisms in the human gene. Genomics 1993;15:21-9.
6. Namba H, Narahara K, Tsuji K, Yokoyama Y, Seino Y. Assignment of human porphobilinogen deaminase to 11q24.1-q24.2 by in situ hybridization and gene dosage studies. Cytogenet Cell Genet 1991;57:105-8.
7. Kauppinen R, Mustajoki P. Prognosis of acute porphyria: Occurrence of acute attacks, precipitating factors, and associated diseases. Medicine (Baltimore) 1992;71:1-13.
8. Llewellyn DH, Smyth SJ, Elder GH, Hutchesson AC, Ratterbury JM, Smith MF. Homozygous acute intermittent porphyria: Compound heterozygosity for adjacent base transitions in the same codon of the porphobilinogen deaminase gene. Hum Genet 1992;89:97-8.
9. Beukeveld GJ, Wolthers BG, Nordmann Y, Deybach JC, Grandchamp B, Wadman SK. A retrospective study of a patient with homozygous form of acute intermittent porphyria. J Inherit Metab Dis 1990;13:673-83.
10. Meyer UA, Strand LJ, Doss M, Rees AC, Marver HS. Intermittent acute porphyria - Demonstration of a genetic defect in porphobilinogen metabolism. N Engl J Med 1972;286:1277-82.
11. Mustajoki P. Normal erythrocyte uroporphyrinogen I synthase in a kindred with acute intermittent porphyria. Ann Intern Med 1981;95:162-6.
12. Moore MR, McColl KEL, Rimington C, Goldberg A. Disorders of Porphyrin Metabolism. New York: Plenum Publishing Corroration. 1987:46-61, 227-55.
13. Mustajoki P, Koskelo P. Hereditary hepatic porphyrias in Finland. Acta Med Scand 1976;200:171-8.
14. Strand LJ, Meyer UA, Felsher BF, Redeker AG, Marver HS. Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria. J Clin Invest 1972;51:2530-6.
15. Li F, Lim CK, Peters TJ. Analysis of urine and faecal porphyrins by HPLC coupled to an advanced automated sample processor. Biomed Chromatogr 1986;1:93-4.
16. Lim CK, Peters TJ. Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. Clin Chim Acta 1984;139:55-63.
17. Poh-Fitzpatrick MB. A plasma porphyrin fluorescence marker for variegate porphyria. Arch Dermatol 1980;116:543-7.
18. Mullis KB, Faloona F. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987;155:335-50.
19. Mustajoki S, Pihlaja H, Ahola H, Petersen NE, Mustajoki P, Kauppinen R. Three splicing defects, an insertion, and two missense mutations responsible for acute intermittent polphyria. Hum Genet 1998;102:541-8.
20. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-termination inhibitors. Proc Natl Acad Sci U S A 1977;74:5463-7.
21. Tschudy DP, Valsamis M, Magnussen CR. Acute intermittent porphyria: Clinical and selected research aspects. Ann Intern Med 1975;83:851-64.
22. Andersson C. Acute Intermittent Porphyria in Northern Sweden. A Population-based Study [PhD Thesis]. Sweden: University of Umeå, 1997:22-3.
23. Mustajoki P, Kauppinen R, Lannfelt L, Koistinen J. Frequency of low porphobilinogen deaminase activity in Finland. J Intern Med 1992;231:389-95.
24. Nordmann Y, Puy H, da Silva V, Simonin S, Robreau AM, Bonaiti C, et al. Acute intermittent porphyria: Prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France. J Intern Med 1997;242:213-7.
25. Bottomley SS, Bonkowsky HL, Kreimer-Birnbaum M. The diagnosis of acute intermittent porphyria. Usefulness and limitations of the erythrocyte uroporphyrinogen I synthase assay. Am J Clin Pathol 1981;76:133-9.
26. Lamon JM, Frykholm BC, Tschudy DP. Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase. J Med Genet 1979;16:134-9.
27. Mustajoki P. Variegate porphyria. Twelve years' experience in Finland. QJM 1980;49:191-203.
28. Fraunberg M, Kauppinen R. The diagnosis of variegate porphyria - Hard to get? Scand J Clin Lab Invest 2000;60:605-10.
29. Anderson KE, Sassa S, Peterson CM, Kappas A. Increased erythrocyte uroporphyrinogen-I-synthetase, δ-aminolevulinic acid dehydratase and protoporphyrin in hemolytic anemias. Am J Med 1977;63:359-64.
30. Blum M, Koehl C, Abecassis J. Variations in erythrocyte uroporphyrinogen I synthetase activity in non porphyrias. Clin Chim Acta 1978;87:119-25.
31. Epstein O, Lahav M, Schoenfeld N, Nemesh L, Shaklai M, Atsmon A. Erythrocyte uroporphyrinogen synthase activity as a possible diagnostic aid in the diagnosis of lymphoproliferative diseases. Cancer 1983;52:828-32.
32. Andriolo A, Mocelin AJ, Stella SR, Ajzen H, Ramos OL. Determination of erythrocyte uroporphyrinogen I synthetase activity in chronic renal failure. Clin Chim Acta 1980;104:241-4.
33. Weinlich G, Doss MO, Sepp N, Fritsch P. Variegate porphyria with coexistent decrease in porphobilinogen deaminase activity. Acta Derm Venereol 2001;81:356-9.
34. Kostrzewska E, Gregor A. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria. Ann Clin Res 1986;18:195-8.